-+ 0.00%
-+ 0.00%
-+ 0.00%

ROIVANT SCIENCES LTD - PHASE 3 MG STUDY MEETS PRIMARY ENDPOINT WITH 5.6 POINT IMPROVEMENT

Reuters·03/19/2025 11:45:00

Please log in to view news